Metabolism of 2-oxo-clopidogrel to the clopidogrel active H4 metabolite using human liver microsomes and its inhibitory effect on ADP-induced human platelet aggregation <i>ex vivo</i>: a confirmatory, placebo-controlled, parallel-group study. [PDF]
Schulz C +4 more
europepmc +1 more source
Pharmacogenetics-Guided De-Escalation of Dual Antiplatelet Therapy Based on CYP2C19 Testing in Patients After Acute Coronary Syndrome: Clinical Outcomes and Cost-Consequence Analysis. [PDF]
Turaev FK +8 more
europepmc +1 more source
Evidence-based Antiplatelet Pretreatment in Non-ST-elevation Acute Coronary Syndromes. [PDF]
Torres-Ruiz G +7 more
europepmc +1 more source
Impact of antiplatelet therapy on erectile dysfunction following percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. [PDF]
Choi J +12 more
europepmc +1 more source
Symptomatic intraocular pressure dysregulation during clopidogrel exposure after patent foramen ovale closure in a patient with ocular hypertension and angle crowding: a Case Report. [PDF]
Li F, Yu R, Guo X, Ji W, Wu Q.
europepmc +1 more source
Effects of Clopidogrel on the Anticonvulsant Efficacy of Valproic Acid and Levetiracetam in a PTZ-Induced Seizure Model. [PDF]
Özdemir S, Bolayir E, Şahin İnan ZD.
europepmc +1 more source
Research progress on de-escalation strategies of dual antiplatelet therapy after acute coronary syndrome. [PDF]
Liu X, Liu J, Xu C.
europepmc +1 more source
When Clopidogrel Reaches the Lung: A Case of Diffuse Interstitial Lung Disease. [PDF]
Phalex EM +4 more
europepmc +1 more source
Clopidogrel-Induced Hypersensitivity Syndrome Presenting as a Progressive Rash: A Case Report. [PDF]
Saghari S, Geha M, Arbabi M, Babary H.
europepmc +1 more source
Cost-Effectiveness of Pharmacogenomics-Guided Treatment in Cardiovascular Disease: An Umbrella Review. [PDF]
Janković SM +8 more
europepmc +1 more source

